Top Conditions
Boxwood (Buxus sempervirens L.)
background
Boxwood is an evergreen shrub native to Southern Europe, Western Asia, and Northern Africa.
An extract of boxwood, SPV-30 (Arkopharma, France), has been studied for its potential effects in HIV and AIDS; however, available clinical evidence is inconclusive. Product claims for SPV-30 have been controversial.
There is currently insufficient available evidence in humans to support the use of boxwood for any medical indication.
synonyms
Benzenemethanethiol, Buxaceae (family), buxozine-C, Buxusbalearica, Buxus sempervirens L., Buxus sempervirens var. bullata, common box, European box, Flu Guard™, SPV30, SPV-30, volatile thiol.
evidence table
These uses have been tested in humans or animals. Safety and effectiveness have not always been proven. Some of these conditions are potentially serious, and should be evaluated by a qualified healthcare provider.
HIV/AIDS
(Grade: C)
Trials have been conducted for SPV30 (extract of boxwood, Arkopharma, France). However, rigorous clinical study is needed to confirm results of SPV30 for HIV infection and AIDS.
Trials have been conducted for SPV30 (extract of boxwood, Arkopharma, France). However, rigorous clinical study is needed to confirm results of SPV30 for HIV infection and AIDS.
©2006-2013
